Boobalan Pachaiyappan

Dr. Boobalan Pachaiyappan is a Managing Director & Senior Research Analyst at ROTH Capital Partners LLC.
He has 13 years of post-Ph.D.
work experience in biomedical sciences, including five years of equity research experience as a sell­side Analyst.
At Roth, he is responsible for fortifying the firm's SMID-cap coverage of emerging growth companies in the Healthcare sector, with a predilection towards neurology, neuropsychiatry, neuromuscular disorders and pain.
Dr. Pachaiyappan embarked on his Equity Research career as an Associate at H.C.
Wainwright and quickly advanced to Vice President and Director roles.
At H.C.
Wainwright, he contributed significantly to 40 initiation reports, holding primary/co-primary responsibility for 20 stocks.
He received his doctorate degree from the University of Illinois.